ZenaTech Announces Dual Listing of Its Shares on the Frankfurt Stock Exchange
04. November 2024 07:30 ET
|
ZenaTech Inc.
TORONTO, Ontario, Nov. 04, 2024 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drone solutions and...
Genius Group Board Approves Dual Listing of its shares on Frankfurt Stock Exchange
13. August 2024 11:35 ET
|
Genius Group Limited
SINGAPORE, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading entrepreneur edtech and education group, announced today that its...
VCI Global Announces Secondary Listing on the Frankfurt Stock Exchange, Expanding its Market Reach
28. Juni 2024 08:08 ET
|
VCI Global Limited
KUALA LUMPUR, Malaysia, June 28, 2024 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, “VCIG”, or the “Company”), a diversified holding company specializing in consulting,...
Atlas Drills Another Large Step-Out at Great Atlantic
10. Juni 2022 10:16 ET
|
Atlas Salt Inc.
ST. JOHN’S, Newfoundland and Labrador, June 10, 2022 (GLOBE NEWSWIRE) -- Atlas Salt (the “Company” or “Atlas” - TSXV: SALT) is pleased to report that as the Company progresses toward completion of...
Biofrontera reports preliminary unaudited sales revenue for the third quarter of 2020
09. Oktober 2020 10:32 ET
|
Biofrontera AG
Leverkusen, Germany, Oct. 09, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reports...
Biofrontera AG plans mediation to resolve (legal) disputes
11. September 2020 07:33 ET
|
Biofrontera AG
Leverkusen, Germany, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company” or the “Biofrontera-Group”), an international biopharmaceutical...
European Medicines Agency recommends indication expansion of Ameluz® for treatment of actinic keratoses on the extremities and trunk/neck
03. Februar 2020 05:45 ET
|
Biofrontera AG
Leverkusen, Germany, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announced today that...
Biofrontera strengthens commercial focus with reorganization of its US business
06. Januar 2020 09:00 ET
|
Biofrontera AG
Leverkusen, Germany, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced a new...
Extraordinary General Meeting of Biofrontera AG: Biofrontera Management Board supported by large majority
20. Dezember 2019 09:35 ET
|
Biofrontera AG
Leverkusen, Germany, Dec. 20, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced the...
Biofrontera Reports Third Quarter 2019 Financial Results and Revises Guidance
19. November 2019 03:25 ET
|
Biofrontera AG
Leverkusen, Germany, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced its...